Medicare Part D coverage · hydroxychloroquine sulfate · RxCUI 979092
hydroxychloroquine sulfate 200 MG Oral Tablet
Per the CMS 2026 Part D formulary file, hydroxychloroquine sulfate 200 MG Oral Tablet is covered by 5,052 Medicare Part D plans (100% of enrollable products), averaging Tier 2, with prior authorization required on 0% of covering formularies.
- 100%
- Plan coverage
- 5,052
- Plans covering
- T2
- Avg tier
- 0%
- Prior auth required
What the CMS Formulary Data Shows for hydroxychloroquine sulfate 200 MG Oral Tablet
Per the CMS 2026 Part D formulary file, hydroxychloroquine sulfate 200 MG Oral Tablet (RxNorm concept RXCUI 979092, generic name hydroxychloroquine sulfate) appears on 328 distinct formulary files spanning 5,052 Medicare Part D plan offerings - 100% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 2.
Real-world access to hydroxychloroquine sulfate 200 MG Oral Tablet depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 29.9% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 583,911 Part D beneficiaries filled hydroxychloroquine sulfate 200 MG Oral Tablet in 2023, with total plan-and-beneficiary spending of $150,719,372 and an average per-beneficiary annual cost of $258.12. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry hydroxychloroquine sulfate 200 MG Oral Tablet today.
Coverage Details
- Formularies covering
- 328
- Plans covering
- 5,052
- Coverage rate
- 100%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 29.9% of formularies
2023 Medicare Spending
- Beneficiaries
- 583,911
- Total spending
- $150,719,372
- Avg per beneficiary
- $258.12
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering hydroxychloroquine sulfate 200 MG Oral Tablet
100 Medicare Advantage plans with Part D drug coverage include this drug.
Show the next 30 plans
Showing top 50 of 100 plans.
Frequently Asked Questions
Is hydroxychloroquine sulfate 200 MG Oral Tablet covered by Medicare Part D?
Yes, hydroxychloroquine sulfate 200 MG Oral Tablet is covered by 5,052 Medicare Part D plans (100% of all Part D formularies).
What tier is hydroxychloroquine sulfate 200 MG Oral Tablet on Medicare Part D plans?
hydroxychloroquine sulfate 200 MG Oral Tablet averages Tier 2 across Part D plans, ranging from Tier 1 to Tier 4.
Does hydroxychloroquine sulfate 200 MG Oral Tablet require prior authorization?
0% of Part D formularies require prior authorization for hydroxychloroquine sulfate 200 MG Oral Tablet. Step therapy: 0%. Quantity limits: 29.9%.
How much does Medicare spend on hydroxychloroquine sulfate 200 MG Oral Tablet?
In 2023, total Medicare Part D spending on hydroxychloroquine sulfate 200 MG Oral Tablet was $150,719,372, covering 583,911 beneficiaries. The average spend per beneficiary was $258.12.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
Similar prior-authorization rate
- metronidazole 10 MG/ML Topical Cream [Noritate] 0% PA
- 24 HR minocycline 40 MG Extended Release Oral Capsule [Emrosi] 0% PA
- buspirone hydrochloride 10 MG Oral Capsule [Bucapsol] 0% PA
- diflunisal 375 MG Oral Tablet [Dolobid] 0% PA
- hydrocortisone 1 MG/ML Oral Solution [Khindivi] 0% PA
- indomethacin 50 MG Rectal Suppository [Indocin] 0% PA